全文获取类型
收费全文 | 42521篇 |
免费 | 3552篇 |
国内免费 | 72篇 |
专业分类
耳鼻咽喉 | 564篇 |
儿科学 | 1113篇 |
妇产科学 | 1024篇 |
基础医学 | 5935篇 |
口腔科学 | 736篇 |
临床医学 | 4989篇 |
内科学 | 8355篇 |
皮肤病学 | 542篇 |
神经病学 | 3516篇 |
特种医学 | 1624篇 |
外国民族医学 | 3篇 |
外科学 | 6583篇 |
综合类 | 684篇 |
一般理论 | 74篇 |
预防医学 | 3748篇 |
眼科学 | 841篇 |
药学 | 3084篇 |
1篇 | |
中国医学 | 26篇 |
肿瘤学 | 2703篇 |
出版年
2023年 | 283篇 |
2022年 | 430篇 |
2021年 | 1278篇 |
2020年 | 656篇 |
2019年 | 1136篇 |
2018年 | 1216篇 |
2017年 | 884篇 |
2016年 | 958篇 |
2015年 | 1104篇 |
2014年 | 1629篇 |
2013年 | 1963篇 |
2012年 | 3057篇 |
2011年 | 3155篇 |
2010年 | 1638篇 |
2009年 | 1478篇 |
2008年 | 2385篇 |
2007年 | 2380篇 |
2006年 | 2220篇 |
2005年 | 2122篇 |
2004年 | 1854篇 |
2003年 | 1662篇 |
2002年 | 1496篇 |
2001年 | 709篇 |
2000年 | 715篇 |
1999年 | 592篇 |
1998年 | 345篇 |
1997年 | 262篇 |
1996年 | 260篇 |
1995年 | 237篇 |
1994年 | 215篇 |
1993年 | 198篇 |
1992年 | 507篇 |
1991年 | 500篇 |
1990年 | 463篇 |
1989年 | 429篇 |
1988年 | 408篇 |
1987年 | 415篇 |
1986年 | 422篇 |
1985年 | 427篇 |
1984年 | 319篇 |
1983年 | 277篇 |
1982年 | 210篇 |
1981年 | 170篇 |
1979年 | 313篇 |
1978年 | 228篇 |
1977年 | 201篇 |
1975年 | 176篇 |
1974年 | 182篇 |
1973年 | 190篇 |
1972年 | 168篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Patrick W. Keeley Mikayla C. Lebo Jordan D. Vieler Jason J. Kim Ace J. St. John Benjamin E. Reese 《The Journal of neuroscience》2021,41(1):103
Amacrine cells of the retina are conspicuously variable in their morphologies, their population demographics, and their ensuing functions. Vesicular glutamate transporter 3 (VGluT3) amacrine cells are a recently characterized type of amacrine cell exhibiting local dendritic autonomy. The present analysis has examined three features of this VGluT3 population, including their density, local distribution, and dendritic spread, to discern the extent to which these are interrelated, using male and female mice. We first demonstrate that Bax-mediated cell death transforms the mosaic of VGluT3 cells from a random distribution into a regular mosaic. We subsequently examine the relationship between cell density and mosaic regularity across recombinant inbred strains of mice, finding that, although both traits vary across the strains, they exhibit minimal covariation. Other genetic determinants must therefore contribute independently to final cell number and to mosaic order. Using a conditional KO approach, we further demonstrate that Bax acts via the bipolar cell population, rather than cell-intrinsically, to control VGluT3 cell number. Finally, we consider the relationship between the dendritic arbors of single VGluT3 cells and the distribution of their homotypic neighbors. Dendritic field area was found to be independent of Voronoi domain area, while dendritic coverage of single cells was not conserved, simply increasing with the size of the dendritic field. Bax-KO retinas exhibited a threefold increase in dendritic coverage. Each cell, however, contributed less dendrites at each depth within the plexus, intermingling their processes with those of neighboring cells to approximate a constant volumetric density, yielding a uniformity in process coverage across the population.SIGNIFICANCE STATEMENT Different types of retinal neuron spread their processes across the surface of the retina to achieve a degree of dendritic coverage that is characteristic of each type. Many of these types achieve a constant coverage by varying their dendritic field area inversely with the local density of like-type neighbors. Here we report a population of retinal amacrine cells that do not develop dendritic arbors in relation to the spatial positioning of such homotypic neighbors; rather, this cell type modulates the extent of its dendritic branching when faced with a variable number of overlapping dendritic fields to approximate a uniformity in dendritic density across the retina. 相似文献
2.
3.
Marike Gabrielson Mattias Hammarström Magnus Bäcklund Jenny Bergqvist Kristina Lång Ann H Rosendahl Signe Borgquist Roxanna Hellgren Kamila Czene Per Hall 《International journal of cancer. Journal international du cancer》2023,152(11):2362-2372
Tamoxifen prevents recurrence of breast cancer and is suggested for preventive risk-reducing therapy. Tamoxifen reduces mammographic density, a proxy for therapy response, but little is known about its effects in remodelling normal breast tissue. Our study, a substudy within the double-blinded dose-determination trial KARISMA, investigated tamoxifen-specific changes in breast tissue composition and histological markers in healthy women. We included 83 healthy women randomised to 6 months daily intake of 20, 10, 5, 2.5, 1 mg of tamoxifen or placebo. The groups were combined to “no dose” (0-1 mg), “low-dose” (2.5-5 mg) or “high-dose” (10-20 mg) of tamoxifen. Ultrasound-guided biopsies were collected before and after tamoxifen exposure. In each biopsy, epithelial, stromal and adipose tissues was quantified, and expression of epithelial and stromal Ki67, oestrogen receptor (ER) and progesterone receptor (PR) analysed. Mammographic density using STRATUS was measured at baseline and end-of-tamoxifen-exposure. We found that different doses of tamoxifen reduced mammographic density and glandular-epithelial area in premenopausal women and associated with reduced epithelium and increased adipose tissue. High-dose tamoxifen also decreased epithelial ER and PR expressions in premenopausal women. Premenopausal women with the greatest reduction in proliferation also had the greatest epithelial reduction. In postmenopausal women, high-dose tamoxifen decreased the epithelial area with no measurable density decrease. Tamoxifen at both low and high doses influences breast tissue composition and expression of histological markers in the normal breast. Our findings connect epithelial proliferation with tissue remodelling in premenopausal women and provide novel insights to understanding biological mechanisms of primary prevention with tamoxifen. 相似文献
4.
5.
6.
Caroline E. Sloan Judy Zhong Dinushika Mohottige Rasheeda Hall Clarissa J. Diamantidis Leight E. Boulware Virginia Wang 《Seminars in dialysis》2020,33(6):440-448
Caring for patients with end-stage kidney disease (ESKD) in the United States is challenging, due in part to the complex epidemiology of the disease's progression as well as the ways in which care is delivered. As CKD progresses toward ESKD, the number of comorbidities increases and care involves multiple healthcare providers from multiple subspecialties. This occurs in the context of a fragmented US healthcare delivery system that is traditionally siloed by provider specialty, organization, as well as systems of payment and administration. This article describes the role of care fragmentation in the delivery of optimal ESKD care and identifies research gaps in the evidence across the continuum of care. We then consider the impact of care fragmentation on ESKD care from the patient and health system perspectives and explore opportunities for system-level interventions aimed at improving care for patients with ESKD. 相似文献
7.
8.
9.
10.